Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Lifeway Foods, Inc.    LWAY


News SummaryMost relevantAll newsOfficial PublicationsSector news

Lifeway Foods, Inc. Announces Results for Fourth Quarter and Year Ended December 31, 2018

share with twitter share with LinkedIn share with facebook
share via e-mail
04/15/2019 | 05:46pm EDT

MORTON GROVE, Ill., April 15, 2019 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for fourth quarter and year ended December 31, 2018.

Julie Smolyansky, Lifeway’s CEO commented, “Our team continues to work diligently on our strategic long-term plan, Lifeway 2.0, to reinvigorate growth. We are pleased with the initial steps we have taken in a very short period of time that are aligned with our key strategies to expand core kefir product distribution, build upon our introduction of convenient, on-the-go health and wellness product innovation, and enhance consumer experiences to increase Lifeway brand trial, awareness and consumption.  We are also taking decisive actions across our organization to align our corporate infrastructure with the return to growth that we aim to achieve over the next several years. While certain of these efforts resulted in higher expenses late in 2018, we expect Lifeway to realize greater efficiencies over time. We believe we are well positioned for growth with our core product offerings and innovation pipeline, including Plantiful, our new plant-based probiotic beverage that has created industry excitement. Our strong manufacturing, sales and marketing foundation is now set to execute our strategic growth plan and enhance value for all of our stakeholders.”

Full Year 2018 Results
Net Sales
Net sales were $103.4 million for the year ended December 31, 2018, a decrease of $15.5 million or 13.1% versus the prior year. The decline was primarily due to volume/mix of 16.6%, partially offset by lower spend in trade promotion and allowances of 1.7%, and partially offset by pricing gains of 1.8%. The decline in volume/mix was primarily driven by volume softness in Lifeway’s branded drinkable and ProBugs kefir, partially offset by the incremental volume of new item introductions. The volume decline reflects lower consumption of the Company’s products that is consistent with the overall volume decline in dairy and cultured dairy product categories. Pricing primarily includes the favorable impact of a second quarter 2018 price increase to recover higher input costs. This increase was partially offset by the lapping of a price reduction driven by the shift in delivery method for select customers in the first quarter 2017. The favorable promotional activity reflects lower trade spending, partially offset by the increased redemptions on the Company’s 2018 coupon program.

Gross Profit
Gross profit as a percentage of net sales was 25.0% for the year ended December 31, 2018. Gross profit percentage was 25.8% in the prior year. The decline versus the prior year was primarily due to the unfavorable impact of operating leverage that arises from lower net sales relative to fixed costs, increased trade promotion investment, and higher freight and fixed costs, partially offset by an increase in pricing and a reduction in variable costs. Additionally, depreciation expense increased reflecting the continued investment in manufacturing improvements. The Company incurred $0.1 million of direct labor severance expense in 2018 to reduce expense and create efficiencies in the Company’s manufacturing process.

Selling Expenses
Selling expenses decreased $3.1 million or 18.8% to $13.5 million for the year ended December 31, 2018. The decrease versus the prior year, primarily reflects a change in media spending to reduce programs with lower efficiency. The primary driver was a reduction in television advertising spend in 2018 compared to the prior year, and to a lesser extent lower broker commissions and marketing spending. The reduction was partially offset by severance expense. The Company incurred $0.3 million of selling severance expense in 2018 to align the organizational structure and reduce expenses.

General and administrative expenses
General and administrative expenses were slightly lower for the year ended December 31, 2018 finishing at $13.6 million, 2.4% below the prior year. This reflects decreased incentive compensation and bad debt expense, partially offset by severance expense. The Company incurred $0.4 million of general and administrative severance expense in 2018 to align its organizational structure and reduce expenses. As noted in the sections above, the Company incurred a total of $0.8 million of severance expense during fiscal year 2018, primarily in the fourth quarter.

As noted in the sections above, the Company incurred a total of $0.8 million of severance expense during fiscal year 2018, primarily in the fourth quarter.

Consolidated Balance Sheets
December 31, 2018 and 2017
(In thousands)

  December 31, 
  2018  2017 
Current assets        
Cash and cash equivalents $2,998  $4,978 
Accounts receivable, net of allowance for doubtful accounts and discounts and allowances of $1,220 and $2,010 at December 31, 2018 and 2017, respectively  6,276   8,676 
Inventories, net  5,817   7,697 
Prepaid expenses and other current assets  1,077   983 
Refundable income taxes  2,748   2,347 
Total current assets  18,916   24,681 
Property, plant and equipment, net  24,573   24,645 
Intangible assets        
Goodwill and indefinite-lived intangibles  12,824   14,068 
Other intangible assets, net  344   975 
Total intangible assets  13,168   15,043 
Other Assets  150   150 
Total assets $56,807  $64,519 
Current liabilities        
Current maturities of notes payable $  $3,166 
Accounts payable  4,570   6,848 
Accrued expenses  2,777   2,984 
Accrued income taxes  106   203 
Total current liabilities  7,453   13,201 
Line of Credit  5,995    
Notes payable     3,113 
Deferred income taxes, net  390   840 
Other long-term liabilities  564   775 
Total liabilities  14,402   17,929 
Stockholders’ equity        
Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at 2018 and 2017      
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,814 and 16,008 shares outstanding at 2018 and 2017  6,509   6,509 
Paid-in capital  2,303   2,244 
Treasury stock, at cost  (12,970)  (11,812)
Retained earnings  46,563   49,649 
Total stockholders’ equity  42,405   46,590 
Total liabilities and stockholders’ equity $56,807  $64,519 

Consolidated Statements of Operations
For the three months and twelve months ended December 31, 2018 and 2017
 (In thousands, except per share data)

  Three Months Ended
December 31,
 Twelve months Ended
December 31,
  2018  2017 2018 2017
Net sales $23,032  $ 26,257  $103,350  $118,893 
Cost of goods sold  17,234   20,495   74,646   85,757 
Depreciation expense  703   639   2,846   2,440 
Total cost of goods sold  17,937   21,134   77,492   88,197 
Gross profit  5,095   5,123   25,858   30,696 
Selling expenses  2,940   4,947   13,477   16,595 
General and administrative  3,765   3,212   13,616   13,955 
Goodwill impairment  1,244      1,244    
Amortization expense  141   168   631   672 
Total operating expenses  8,090   8,327   28,968   31,222 
Loss from operations  (2,995)  (3,204)  (3,110)  (526)
Other income (expense):             
Interest expense  (51)  (62)
  (271)  (242)
Gain (loss) on sale of property and equipment  12   1   54   (38)
Other income  5   2   16   2 
Total other expense  (34)  (59)
  (201)  (278)
Loss before provision for income taxes  (3,029)  (3,263)  (3,311)
Benefit for income taxes  (217)  (1,514)  (225)  (458)
Net loss $(2,812) $(1,749) $(3,086) $(346)
Loss per common share:             
Basic $(0.18) $(0.11) $(0.19)
Diluted $(0.17) $(0.11) $(0.19)
Weighted average common shares:             
Basic  15,831   16,018   15,872   16,105 
Diluted  16,221   16,018   16,319   16,105 

Consolidated Statements of Cash Flows
For the Years Ended December 31, 2018 and 2017
(In thousands)

  2018  2017 
Cash flows from operating activities:        
Net loss $(3,086) $(346)
Adjustments to reconcile net loss to operating cash flow:        
Depreciation and amortization  3,477   3,112 
Non-cash interest expense  14    
Bad debt expense  21   480 
Deferred Revenue  (97)   
Reserve for inventory obsolescence  558   374 
Stock-based compensation  802   596 
Deferred income taxes  (451)  (352)
(Gain) loss on sale of property and equipment  (54)  38 
Goodwill impairment  1,244    
(Increase) decrease in operating assets:        
Accounts receivable  2,379   780 
Inventories  1,322   (29)
Refundable income taxes  (401)  (2,038)
Prepaid expenses and other current assets  (78)  (197)
Increase (decrease) in operating liabilities:        
Accounts payable  (2,278)  1,130 
Accrued expenses  (858)  711 
Accrued income taxes  (97)  (451)
Net cash provided by operating activities  2,417   3,808 
Cash flows from investing activities:        
Purchases of investments  (500)  (25)
Proceeds from sale of investments  500    
Purchases of property and equipment  (2,824)  (5,341)
Proceeds from sale of property and equipment  104   50 
Net cash used in investing activities  (2,720)  (5,316)
Cash flows from financing activities:        
Borrowings under revolving credit facility  6,050    
Payment of deferred financing costs  (69)   
Purchase of treasury stock  (1,379)  (1,486)
Repayment of notes payable  (6,279)  (840)
Net cash used in financing activities  (1,677)  (2,326)
Net decrease in cash and cash equivalents  (1,980)  (3,834)
Cash and cash equivalents at the beginning of the period  4,978   8,812 
Cash and cash equivalents at the end of the period $2,998  $4,978 
Supplemental cash flow information:        
Cash paid for income taxes, net of refunds $723  $2,382 
Cash paid for interest  261   241 

About Lifeway Foods, Inc.

Lifeway Foods, Inc., which has been recognized as one of Forbes’ Best Small Companies, is America’s leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces the non-dairy Plantiful probiotic beverages, cupped kefir and skyr, frozen kefir, specialty cheeses, probiotic supplements and a ProBugs line for kids. Lifeway’s tart and tangy fermented dairy and non-dairy products are now sold across North America, Ireland and the United Kingdom. Learn how Lifeway is good for more than just you at www.lifewaykefir.com.

Forward-Looking Statements

All statements in this release (and oral statements made regarding the subjects of this release) contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position, business strategy and objectives. These statements use words, and variations of words, such as "expand," "build," "enhance," "take," "action," "align," "return," "aim, "achieve," "expect," "realize," "believe," "position," "grow," and "execute." Other examples of forward looking statements may include, but are not limited to, (i) statements of Company plans and objectives, including the introduction of new products, or estimates or predictions of actions by customers or suppliers, (ii) statements of future economic performance, and (III) statements of assumptions underlying other statements and statements about Lifeway or its business. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway’s expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, and the Company’s subsequent filings with the SEC. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Information in this release is as of the dates and time periods indicated herein, and Lifeway does not undertake to update any of the information contained in these materials, except as required by law. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED PRESS RELEASE.


Lifeway Foods, Inc.
Phone: 847-967-1010
Email: info@lifeway.net


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on LIFEWAY FOODS, INC.
06/25LIFEWAY FOODS : to Participate in Oppenheimer's 19th Annual Consumer Conference ..
06/24Lifeway Foods, Inc., CEO Julie Smolyansky to Present at the 13th Annual Globa..
06/21LIFEWAY FOODS, INC. : Submission of Matters to a Vote of Security Holders, Regul..
06/20Lifeway Foods Announces Plans to Enter Growing CBD Category with Plantiful + ..
06/14Lifeway Foods, Inc., to Participate in Oppenheimer's 19th Annual Consumer Con..
05/20LIFEWAY : 1Q Earnings Snapshot
05/20Lifeway Foods, Inc. Announces Results for the First Quarter Ended March 31, 2..
04/19LIFEWAY FOODS : 10-k/a - management's discussion and analysis of financial condi..
04/15LIFEWAY : 4Q Earnings Snapshot
More news
Financials (USD)
Sales 2018 -
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019 -
Capi. / Sales2018 -
Capi. / Sales2019 -
Capitalization 51,3 M
Duration : Period :
Lifeway Foods, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LIFEWAY FOODS, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus -
Number of Analysts
Average target price
Last Close Price 3,25  $
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Julie Smolyansky President, Chief Executive Officer & Director
Ludmila Smolyansky Chairman
Edward P. Smolyansky COO, Secretary, Treasurer & Director
Eric Hanson Chief Financial & Accounting Officer
Renzo Bernardi Independent Director
Sector and Competitors